Coste, Astrid http://orcid.org/0000-0003-4207-7447
Wong, Angel YS
Warren-Gash, Charlotte
Matthewman, Julian
Bate, Andrew
Douglas, Ian J.
Funding for this research was provided by:
GlaxoSmithKline
Article History
Accepted: 14 November 2023
First Online: 13 December 2023
Declarations
:
: Astrid Coste is funded by a GSK PhD studentship to undertake this work.
: Andrew Bate is an employee of GSK and holds stocks and stock options. However, Andrew Bate did not actively participate in the assessment of the labels and choice of outcomes for this methodological study. Ian J. Douglas holds grants and shares from GSK. GSK markets the following drugs: amoxicillin. Charlotte Warren-Gash is funded by a Wellcome Career Development Award (225868/Z/22/Z). Angel Wong and Julian Matthewman have no conflicts of interest that are directly relevant to the content of this article.
: This study has been approved by the London School of Hygiene and Tropical Medicine Ethics Committee (approval number 27650).
: Not applicable, as no human or animal data were used to conduct this study.
: Not applicable, as no human or animal data were used to conduct this study.
: All data generated or analysed during this study are included in this published article and its supplementary information files.
: Not applicable.
: AC, AW, AB and IJD have contributed to the design of the study. AC was responsible for conducting the study and drafting the manuscript, which has been reviewed by all co-authors. CWG and JM have contributed to the selection of the outcomes. All authors read and approved the final version.